Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
November 16, 2025 — Simcere Pharmaceutical Group (02096.HK) announced today that the National Medical Products Administration (NMPA) of China has appr...
November 10, 2026 — Simcere Pharmaceutical Group (02096.HK) announced today that SIM0725, its proprietary long-acting antagonist monoclonal antibody t...
Shanghai, China, 9 November 2026 – Simcere Pharmaceutical Group Ltd. (“Simcere”) (HKEX: 2096) today announced that SIM0709, a TL1A/IL-23p19 bispecific...
November 6, 2026 — Simcere Pharmaceutical Group (02096) announced today that the New Drug Application (NDA) for zemprocitinib—an orally administered, ...